Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™ [Yahoo! Finance]
Waldencast plc - Class A Ordinary Share (WALD)
Company Research
Source: Yahoo! Finance
NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced Schweiger Dermatology as a key partner for the Aesthetics Leadership with Obagi's Hyaluronic Acid (ALOHA) Program. Schweiger will help generate real-world data to translate the clinical safety and efficacy demonstrated in FDA pivotal trials into everyday practice across multiple trials and evaluation programs. “This partnership with Obagi makes perfect sense for us. They're taking a thoughtful, evidence-based approach to introducing this innovative injectable, and we have the clinical depth and scale to evaluate how trial data translates into real-world outcomes across our diverse patient base,” said Dr. David Goldberg, Director of Cosmetic Dermatology and Clinical Research at Schweiger Dermatology. “Our providers see thousands of patients daily for both med
Show less
Read more
Impact Snapshot
Event Time:
WALD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WALD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WALD alerts
High impacting Waldencast plc - Class A Ordinary Share news events
Weekly update
A roundup of the hottest topics
WALD
News
- Waldencast (WALD) had its price target lowered by Telsey Advisory Group from $3.00 to $2.00. They now have a "market perform" rating on the stock.MarketBeat
- Waldencast (WALD) had its price target lowered by Canaccord Genuity Group Inc. from $4.00 to $2.00. They now have a "buy" rating on the stock.MarketBeat
- Waldencast Reports Q4 2025 and FY 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Waldencast Reports Q4 2025 and FY 2025 Financial ResultsGlobeNewswire
- Waldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings DateGlobeNewswire
WALD
Sec Filings
- 3/13/26 - Form 6-K
- 3/13/26 - Form 20-F
- 3/11/26 - Form 6-K
- WALD's page on the SEC website